Elysium Health Prioritizes Long Term Health

Elysium Health, a biotechnology company that could revolutionize the market, attempts to disrupt the pill market with its food supplement-type drugs that can reduce the aging effects. Interestingly, the drug developed by the firm has shown excellent results in worms and mice and extended their lifespan significantly. Due to the long lifespan of humans, it is found that the new drug may take decades to prove the results in humans to supply it as an approved drug. Due to that, the founders of Elysium Health went for an unconventional root and introduced the drug as nutraceuticals. Interestingly, those drugs do not need any approvals or clinical trials from FDA.

Finally, Elysium Health came up with its over the counter pill named Basis that has the power to keep people young. It has a chemical initiator to NAD or nicotinamide adenine dinucleotide. NAD is a compound the human cells use to execute metabolic reactions including energy release from glucose. It can cause similar effects to the diets of people that have a significant shortage of calories – the factor that helped a mouse live for a longer period. Interestingly, the drug that comes with strict production standards is available from its official website at $60 for a 30-day plan. However, if people choose a continued subscription plan, they can get the drug at $50 per month.https://www.technologyreview.com/s/534636/the-anti-aging-pill/

Compared to high-end prescription medicines available in the market, the drug from Elysium Health is highly cheap. Interestingly, the company has some high-level endorsements, and five Nobel laureate winners are providing guidance and assistance to the firm. Interestingly, the scientists could prove that the lifespan of mice could be extended considerably by feeding the drug using the technique called “caloric restriction.” It is identified that the level of NAD decreases by age in every animal, including humans. By supplying the drug, it increases the NAD molecule content in the human cells. Many prominent researchers agreed that NAD replacement is the most revolutionary thing that can happen in long term wellness. This approves the working mechanism of Elysium Health’s pill.

Elysium Health was founded in the year 2014 to develop effective medication for one of the most challenging aspects of health – the aging. The firm collaborates with leading physicians and medical researchers around the world to come up with solutions that can provide results at the cellular level. Elysium Health was founded by Eric Marcotulli, a former Sequoia partner; Dan Alminana, former JPMorgan vice president; and Leonard Guarente, an MIT professor. The company follows a business approach of food supplements and tries to help the people to get the multivitamin needs of day to day life through bottles. Interestingly, all its solutions are aimed to improve the cell health, and that converts to the overall health of the human beings.


Clay Siegall: The Zealous Cancer Therapies Researcher

Cancer as globally known as the world’s leading chronic killer disease. To date, curative treatments are yet to be formulated. However, medical researchers and scientists have not relented. They are still determined to fight off this enormous medical giant from the lives of people. Fortunately, these very skilled experts have been able to formulate various therapies and treatments that can curtail the spread, development, and also the effects of this killer disease. In the front line of this battle are Dr. Clay Siegall and Seattle Genetics.


Dr. Clay Siegall is the founder and current CEO of Seattle Genetics, a biotech firm that majors in the development of targeted therapy drugs for cancer. The company is located in Seattle. The respected scientist holds a Bachelor of Science in Zoology from the University of Maryland. More so, he has a Ph.D. in Genetics from the University of George Washington.


Dr. Clay Siegall explains that his career choice was prompted by the fact that medicine always fascinated him. With the new technologies, the idea interested him the more, and he wanted to personally experience the power and might of the advanced technology and reason to suppress the dominance of diseases in the world.


He continues to say that his interest became more real while pursuing his higher education. At that moment, his father fell sick and was diagnosed with cancer. The available treatment at the time was brutal such that he almost succumbed to death, not because of the ailment but the adverse effects of the chemotherapy treatment. In an effort to discover other treatment options, Clay’s desire was hatched, and he went ahead to base his career on it.


Dr. Clay Siegall explains how his company makes money. For starters, the firm sells its proprietary drugs, mostly the ADC. Besides, it reaps substantial revenues from production partnerships and licensing of technologies and processes. He explains that the entity has had its handful of struggles especially with capital issues but has since been resolved, and its operations have never ceased.


Dr. Clay Siegall has spanned a successful career with Seattle Genetics but has also served in other respectable institutions. He has worked at Bristol-Myers Squibb Pharmaceutical Research Institute, the National Cancer Institute, and also the National Institute of Health. Besides, he serves on the Board of Directors of Alder Bio-pharmaceuticals, and he has also authored over 70 scientific journals and is a holder of 15 patents. Dr. Siegall attributes his success to hard work, great focus, and passion.